Stock Price
2.07
Daily Change
-0.03 -1.20%
Monthly
-14.32%
Yearly
-6.14%
Q1 Forecast
2.07

Mesoblast reported $574.68M in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Avita Medical AUD -16.65M 3.76M Dec/2025
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Cochlear AUD 1.94B 12.2M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Pacific Edge NZD 26.9M 811K Dec/2025
Paradigm Biopharmaceuticals AUD 21.18M 12.88M Jun/2025
PYC Therapeutics AUD 147.18M 22.82M Dec/2025
Ramsay Health Care AUD 4.79B 916.1M Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Starpharma Holdings AUD 21.48M 2.48M Dec/2025
Telix Pharmaceuticals AUD 416.86M 5.08M Dec/2025